EGFR and neoplasm: At the molecular level, increased EGFR autophosphorylation and upregulation of EGFR ligands reactivate downstream cascades such as the phosphatidylinositol 3-kinase (PI3K)/AKT and MAPK/ERK pathways, enabling tumor cells to reduce dependence on ALK signaling[41].